Roth JA - Search Results

1

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.

Stewart CA, Gay CM, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J, Bolisetty M, Hartsfield PM, Balasubramaniyan V, Chalishazar MD, Moran C, Kalhor N, Stewart J, Tran H, Swisher SG, Roth JA, Zhang J, de Groot J, Glisson B, Oliver TG, Heymach JV, Wistuba I, Robson P, Wang J, Byers LA. Stewart CA, et al. Among authors: roth ja. Nat Cancer. 2020 Apr;1:423-436. doi: 10.1038/s43018-019-0020-z. Epub 2020 Feb 17. Nat Cancer. 2020. PMID: 33521652 Free PMC article.

2

Combination immunotherapy for advanced lung cancer.

Yang SC, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Natl Cancer Inst Monogr. 1992;(13):197-201. J Natl Cancer Inst Monogr. 1992. PMID: 1327033 Clinical Trial.

3

New approaches to treating early lung cancer.

Roth JA. Roth JA. Cancer Res. 1992 May 1;52(9 Suppl):2652s-2657s. Cancer Res. 1992. PMID: 1562995 Review.

4

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

5

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: roth ja. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

6

Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets.

Yang SC, Owen-Schaub L, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Immunol Immunother. 1989;29(3):193-8. doi: 10.1007/BF00199995. Cancer Immunol Immunother. 1989. PMID: 2543502 Free PMC article.

7

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA. Schneider PM, et al. Among authors: roth ja. Cancer Res. 1989 Sep 15;49(18):4968-71. Cancer Res. 1989. PMID: 2569928

8

Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.

Roth JA, Thomsen S, Fry KD, Scannon P, Chang C. Roth JA, et al. Cancer Res. 1989 Oct 15;49(20):5708-12. Cancer Res. 1989. PMID: 2676148

9

Molecular events in lung cancer.

Roth JA. Roth JA. Lung Cancer. 1995 Jun;12 Suppl 2:S3-15. doi: 10.1016/s0169-5002(10)80002-9. Lung Cancer. 1995. PMID: 7551947 Review.

10

Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.

Jin X, Nguyen D, Zhang WW, Kyritsis AP, Roth JA. Jin X, et al. Among authors: roth ja. Cancer Res. 1995 Aug 1;55(15):3250-3. Cancer Res. 1995. PMID: 7614457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,235 results

Search Page